Affiliation:
1. Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden
2. Department of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
Abstract
Over the past decade, the treatment of rectal cancer has changed considerably. The implementation of TME surgery has, in addition to decreasing the number of local recurrences, improved surgical morbidity and mortality. At the same time, the optimisation of radiotherapy in the preoperative setting has improved oncological outcomes even further, although higher perineal infection rates have been reported. Radiotherapy regimens have evolved through the adjustment of radiotherapy techniques and fields, increased waiting intervals, and, for more advanced tumours, adding chemotherapy. Concurrently, imaging techniques have significantly improved staging accuracy, facilitating more precise selection of advanced tumours. Although chemoradiotherapy does lead to the downsizing and -staging of these tumours, a very clear effect on sphincter-preserving surgery and the negative resection margin has not been proven. Aiming to decrease distant metastasis and improve overall survival for locally advanced rectal cancer, systemic chemotherapy can be added to radiotherapy, known as total neoadjuvant treatment (TNT). High complete response rates, both pathological (pCR) and clinical (cCR), are reported after TNT. Patients who follow a Watch & Wait program after a cCR can potentially avoid surgical morbidity and colostomy. For both early and more advanced tumours, trials are now investigating optimal regimens in an attempt to offer organ preservation as much as possible. Multidisciplinary deliberation should include patient preference, treatment toxicity, and likelihood of end colostomy, but also the burden of intensive surveillance in a W&W program.
Funder
European Union’s Horizon 2020
Reference62 articles.
1. Recurrence and survival after total mesorectal excision for rectal cancer;Heald;Lancet,1986
2. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project;Martling;Lancet,2000
3. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Wyrwicz;Ann. Oncol.,2017
4. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial;Marijnen;Lancet Oncol.,2011
5. Swedish Rectal Cancer Trail, Cedermark, B., Dahlberg, M., Glimelius, B., Pahlman, L., Rutqvist, L.E., and Wilking, N. (1997). Improved survival with preoperative radiotherapy in resectable rectal cancer. N. Engl. J. Med., 336, 980–987.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献